Skip to main content
logo
Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
2.700
-0.030 (-1.10%)
Jul 24, 2025, 4:00 PM - Market closed

Company Description

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms.

It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Achieve Life Sciences, Inc.
Achieve Life Sciences logo
CountryUnited States
IndustryBiotechnology
SectorHealthcare
Employees25
CEORichard A. Stewart

Contact Details

Address:
22722 29th Dr. SE, Suite 100
Bothell, Washington 98021
United States
Phone604 210 2217
Websiteachievelifesciences.com

Stock Details

Ticker SymbolACHV
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000949858
CUSIP Number004468203
ISIN NumberUS0044685008
Employer ID95-4343413
SIC Code2835

Key Executives

NamePosition
Dr. Richard A. B. StewartChief Executive Officer and Executive Director
Mark K. Oki CPAChief Financial Officer
Jerry WanVice President of Finance and Principal Accounting Officer
Dr. Anthony Clarke Ph.D.Chief Scientific Officer
Jaime XinosChief Commercial Officer
Dr. Mark L. RubinsteinHead of Medical Affairs
Craig DonnellyExecutive Vice President of CMC and Regulatory CMC

Latest SEC Filings

DateTypeTitle
Jul 16, 2025SCHEDULE 13G/AFiling
Jun 27, 20258-KCurrent Report
Jun 27, 2025424B5Filing
Jun 26, 2025424B5Filing
Jun 6, 20258-KCurrent Report
May 13, 202510-QQuarterly Report
May 13, 20258-KCurrent Report
May 9, 2025SCHEDULE 13G/AFiling
Apr 30, 2025SCHEDULE 13G/AFiling
Apr 28, 2025ARSFiling
View All SEC Filings